CERU Insider Trading Activity and SEC Form 4 Filings
CERU insider trading summary
No open-market insider purchases or sales of Cerulean Pharma Inc. (CERU) have been reported on SEC Form 4 in the past 12 months.
Latest CERU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 22, 2016 | David R Walt | Director | Buy | $1K (591 @ $2.09) |
| Feb 19, 2016 | David R Walt | Director | Buy | $4K (1,700 @ $2.08) |
| Feb 18, 2016 | David R Walt | Director | Buy | $9K (4,500 @ $2.09) |
| Feb 17, 2016 | David R Walt | Director | Buy | $9K (4,460 @ $2.12) |
| Feb 16, 2016 | David R Walt | Director | Buy | $9K (4,500 @ $2.00) |
| Feb 12, 2016 | David R Walt | Director | Buy | $9K (4,311 @ $2.00) |
| Feb 11, 2016 | David R Walt | Director | Buy | $9K (4,350 @ $2.03) |
| Feb 10, 2016 | David R Walt | Director | Buy | $9K (4,500 @ $2.08) |
| Feb 9, 2016 | David R Walt | Director | Buy | $9K (4,500 @ $2.08) |
| Feb 8, 2016 | David R Walt | Director | Buy | $10K (4,500 @ $2.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.